Senior Director, Global Health Outcomes, ViiV Healthcare
The posting period will end on the 3rd of June in 2026
Business Introduction:
We are a specialist pharmaceutical company 100% dedicated to developing medicines to treat and prevent HIV. Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, our ambition is to end the HIV epidemic.
As the pioneers in HIV innovation, we constantly look to push the boundaries of science to develop medicines that can change lives and give people more choice. Beyond our medicines, we are proud of our deep connection with the HIV community and work with partners to advance research and development, address HIV-related stigma, increase access to our medicines and provide funding and support to local community organisations to support their efforts in the HIV response.We are ViiV Healthcare.
Here until HIV and AIDS are not.
Position summary:
You will lead a global health outcomes function within ViiV Healthcare at GSK. You will design and deliver robust evidence generation to support development, access, reimbursement and lifecycle management of HIV treatment and prevention medicines. You will work across research and development, medical affairs, market access, commercial and external stakeholders to shape fit-for-purpose evidence plans. We value clear scientific judgement, leadership that builds capability, and collaborative styles that bring people together. This role requires strong scientific judgement, strategic leadership, and the ability to operate in a complex matrix environment to ensure ViiV’s medicines are supported by credible, decision-relevant evidence that optimizes patient access and value demonstration. You will also shape a forward-looking Clinical Outcomes Assessment (COA) and Patient-Centered Outcomes (PCO) portfolio strategy, ensuring differentiated endpoints are embedded early in development to demonstrate meaningful patient, clinical, and healthcare system value.